Pfizer in the Bay Area – Not just another Big Pharma-Margi McLoughlin, Ph.D.-05/12/2009 - 6:00pm

Event Information
Event Topic: 
Pfizer in the Bay Area – Not just another Big Pharma
Event Date: 
05/12/2009 - 6:00pm
Event Location: 
Palo Alto
Speaker Information
Event Speaker: 
Margi McLoughlin, Ph.D.
Event Speaker Title: 
Senior Director, Worldwide Business Development
Event Speaker Company: 
Pfizer, Inc.
Event Speaker Bio: 

Margi McLoughlin, Ph.D., is a Senior Director in Worldwide Business Development (WWBD) at Pfizer based in South San Francisco, CA. Margi works within Pfizer’s Biotherapeutics Bioinnovation Center (BBC) to develop and execute on external investment strategies and alliances that maximally contribute to the BBC’s internal activities. Margi received a Ph.D. in chemistry from the University of California at Santa Barbara and completed postdoctoral work at Washington University in St. Louis. She then took a position in Discovery Research at Mallinckrodt Medical, developing diagnostic pharmaceuticals for nuclear medicine, MR and X-ray imaging. After five years in the laboratory, Margi spent two years in Technology Planning at Mallinckrodt Medical, where she supported internal R&D through outside alliances. In 1999, she moved to Yale University where she worked as Associate Director in the Office of Cooperative Research. Her responsibilities, at Yale, included patenting, and licensing technologies developed in the School of Medicine. Since joining the Pfizer in 2001, she has had roles of increasing responsibility in WWBD and has played a significant role in Pfizer transactions with Abgenix, Medarex, Incyte, Coley, Scil and FivePrime.

Event Details
$6 - Students/In-transition
$11 - Early-bird Registration
$20 - Late Registration
$25 - Walk-ins
Event Details: 

The presentation will cover the changing organization at Pfizer and its business model with respect to the Bay Area as well as challenges faced by big pharma companies globally and how that impacts our approach to licensing/deals.